Continuous surveillance of invasive pneumococcal disease is key

Lancet Infect Dis. 2021 Jan;21(1):13-14. doi: 10.1016/S1473-3099(20)30294-2. Epub 2020 Jul 20.

Authors

Mirjam J Knol¹, Arie van der Ende²

Affiliations

¹ National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: mirjam.knol@rivm.nl.
² National Reference Laboratory for Bacterial Meningitis, Amsterdam University Medical Center, Amsterdam, the Netherlands.

PMID: 32702304
DOI: 10.1016/S1473-3099(20)30294-2

No abstract available

Publication types

Comment

MeSH terms

Belgium
Child
Humans
Pneumococcal Infections* / epidemiology
Pneumococcal Infections* / prevention & control
Pneumococcal Vaccines
Retrospective Studies
Vaccines, Conjugate

Substances

Pneumococcal Vaccines
Vaccines, Conjugate